Evaluation of Diode Laser Therapy for Peri-Implantitis
Objective
To assess the effectiveness of diode laser therapy as an adjunct to non-surgical mechanical therapy in managing peri-implantitis.
Methods
A cohort of 27 participants with peri-implantitis diagnosis received either diode laser therapy or non-laser treatment. Clinical parameters and peri-implant crevicular fluid (PICF) samples were evaluated at baseline, 3 months, and 6 months. Biomarker levels in the PICF were measured using enzyme-linked immunosorbent assay.
Results
Both groups showed improvements in clinical and biochemical parameters over time. Differences were observed between the groups at the 3-month follow-up, particularly in certain biomarker levels, but not at the 6-month follow-up.
Conclusions
Diode laser therapy appears to be beneficial as an adjunct to non-surgical treatment for early-stage peri-implantitis. Certain biomarkers may be useful for assessing the efficacy of peri-implantitis treatment.
Clinical Relevance
Using diode laser therapy alongside non-surgical treatment may lead to better clinical and immunological improvements during the early healing period. However, no long-term differences were observed between the two methods.
Practical Solutions and Value
Clinical trials are essential for developing safe and effective treatments. Our AI-driven platform, DocSym, consolidates clinical standards and research, making it easier for clinicians to access relevant knowledge. Additionally, our mobile apps support scheduling, treatment monitoring, and telemedicine, streamlining operations and improving patient care.
